Vestal Point Capital »

BioMarin Pharmaceutical shares owned by Vestal Point Capital

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $28M 400k 70.29

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical